|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
OSI Group withdraws Shanghai Husi’s products to rebuild consumer trust
|
|
Tuesday, 29 July, 2014, 08 : 00 AM [IST]
|
|
Shanghai
|
|
fiogf49gjkf0d To help rebuild the trust of its customers and consumers, as well as to cooperate with the official investigatory process, OSI Group withdrew all products manufactured by Shanghai Husi from the marketplace.
The company is also conducting a thorough internal investigation into any possible failures on the part of current and former senior management.
“Should any misconduct be uncovered, we would take swift and decisive action against those responsible, including all relevant disciplinary and/or legal measures. In addition, a new management team has been brought in to China to ensure that operations run effectively,” it added.
Brent Afman, senior vice-president and managing director, OSI Asia Pacific, the Middle-East and Africa (APMEA), said, “These decisions are the most responsible course of action we can take at this point in time. We are working hard to bring assurance to our customers and ultimate consumers.”
In an earlier statement, Sheldon Lavin, owner, OSI Group, also said, “For more than 100 years, we have provided safe, quality food, while operating at the highest global standards.”
“So to have this occur at the Shanghai facility violates the tenets of our company and the values that we embrace and live. It is devastating, and it is not who we are as a company,” he added.
“I am appalled that something so completely unacceptable has happened in a company that I own. I will not try and defend it or explain it. It was just terribly wrong,” Lavin stated.
OSI stated that it would conduct a full, fair, and comprehensive investigation on managers at all levels for evidence of management failures.
“In the meantime, our local operations would be managed by the global management in accordance with the global standards of quality management,” the company stated.
Afman also mentioned the OSI’s global support teams would arrive in Shanghai, and work closely with the local team with the conducting of a ‘leave no stone unturned’ investigation, and, as part of this process, OSI has been and would continue to fully cooperate with the State and Shanghai Food and Drug Administration (FDA) and other regulatory organisations.
“We are committed to openness and transparency. We are providing clear and full explanations and findings to all concerned as early as possible,” he added.
Towards the end of his remarks, Afman stated, “We remain committed to our presence in China, and have sent our best team of global experts to ensure we resolve this.”
“We are very proud of our team members and our operations in other parts of China. It reinforces our confidence and commitment to China. We have a great deal yet to deliver to China,” he added.
|
|
|
|
|
|
|
|
|
|